Skip to main content
OpenTrials

Clinical trial condition

Hormone Receptor+/Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer

Explore clinical trials studying Hormone Receptor+/Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Hormone Receptor+/Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer trial results

Recruiting

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

NCT06084481

Conditions
Adenocarcinoma, Biliary Tract Cancers, Biliary Tract Diseases, +31 more
Locations
  • City of Hope National Medical Center /ID# 258645 Duarte, California, United States
  • University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128 Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE - Denver /ID# 258926 Denver, Colorado, United States
  • Florida Cancer Specialists /ID# 261569 Sarasota, Florida, United States
View all 54 locations
View Trial Details

Related conditions